Cargando…

The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme

BACKGROUND: Cardiovascular diseases (CVD) are the leading cause of death and the third cause of disability in Europe. Prevention programmes should include interventions aimed at a reduction of medical risk factors (hypertension, hypercholesterol, hyperglycemia, overweight and obesity) as well as beh...

Descripción completa

Detalles Bibliográficos
Autores principales: Claes, Neree, Jacobs, Nele
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2045658/
https://www.ncbi.nlm.nih.gov/pubmed/17784946
http://dx.doi.org/10.1186/1471-2261-7-27
_version_ 1782137141106573312
author Claes, Neree
Jacobs, Nele
author_facet Claes, Neree
Jacobs, Nele
author_sort Claes, Neree
collection PubMed
description BACKGROUND: Cardiovascular diseases (CVD) are the leading cause of death and the third cause of disability in Europe. Prevention programmes should include interventions aimed at a reduction of medical risk factors (hypertension, hypercholesterol, hyperglycemia, overweight and obesity) as well as behavioural risk factors (sedentary lifestyle, high fat intake and low fruit and vegetable intake, smoking). The aim of this study is to investigate the effects of a multifaceted, multidisciplinary electronic prevention programme on cardiovascular risk factors. METHODS/DESIGN: In a randomized controlled trial, one group will receive a maximal intervention (= intervention group). The intervention group will be compared to the control group receiving a minimal intervention. An inclusion of 350 patients in total, with a follow-up of 3 years is foreseen. The inclusion criteria are age between 25–65 and insured by the Onderlinge Ziekenkas, insuring for guaranteed income in case of illness for self-employed. The maximal intervention group receives several prevention consultations by their general practitioner (GP) using a new type of cardiovascular risk calculator with personalised feedback on behavioural risk factors. These patients receive a follow-up with intensive support of health behaviour change via different methods, i.e. a tailored website and personal advice of a multidisciplinary team (psychologist, physiotherapist and dietician). The aim of this strategy is to reduce cardiovascular risk factors according to the guidelines. The primary outcome measures will be cardiovascular risk factors. The secondary outcome measures are cardiovascular events, quality of life, costs and incremental cost effectiveness ratios. The control group receives prevention consultations using a new type of cardiovascular risk calculator and general feedback. DISCUSSION: This trial incorporates interventions by GPs and other health professionals aiming at a reduction of medical and behavioural cardiovascular risk factors. An assessment of clinical, psychological and economical outcome measures will be performed. TRIAL REGISTRATION: ISRCTN23940498
format Text
id pubmed-2045658
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-20456582007-10-31 The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme Claes, Neree Jacobs, Nele BMC Cardiovasc Disord Study Protocol BACKGROUND: Cardiovascular diseases (CVD) are the leading cause of death and the third cause of disability in Europe. Prevention programmes should include interventions aimed at a reduction of medical risk factors (hypertension, hypercholesterol, hyperglycemia, overweight and obesity) as well as behavioural risk factors (sedentary lifestyle, high fat intake and low fruit and vegetable intake, smoking). The aim of this study is to investigate the effects of a multifaceted, multidisciplinary electronic prevention programme on cardiovascular risk factors. METHODS/DESIGN: In a randomized controlled trial, one group will receive a maximal intervention (= intervention group). The intervention group will be compared to the control group receiving a minimal intervention. An inclusion of 350 patients in total, with a follow-up of 3 years is foreseen. The inclusion criteria are age between 25–65 and insured by the Onderlinge Ziekenkas, insuring for guaranteed income in case of illness for self-employed. The maximal intervention group receives several prevention consultations by their general practitioner (GP) using a new type of cardiovascular risk calculator with personalised feedback on behavioural risk factors. These patients receive a follow-up with intensive support of health behaviour change via different methods, i.e. a tailored website and personal advice of a multidisciplinary team (psychologist, physiotherapist and dietician). The aim of this strategy is to reduce cardiovascular risk factors according to the guidelines. The primary outcome measures will be cardiovascular risk factors. The secondary outcome measures are cardiovascular events, quality of life, costs and incremental cost effectiveness ratios. The control group receives prevention consultations using a new type of cardiovascular risk calculator and general feedback. DISCUSSION: This trial incorporates interventions by GPs and other health professionals aiming at a reduction of medical and behavioural cardiovascular risk factors. An assessment of clinical, psychological and economical outcome measures will be performed. TRIAL REGISTRATION: ISRCTN23940498 BioMed Central 2007-09-04 /pmc/articles/PMC2045658/ /pubmed/17784946 http://dx.doi.org/10.1186/1471-2261-7-27 Text en Copyright © 2007 Neree and Jacobs; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Claes, Neree
Jacobs, Nele
The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme
title The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme
title_full The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme
title_fullStr The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme
title_full_unstemmed The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme
title_short The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme
title_sort precardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2045658/
https://www.ncbi.nlm.nih.gov/pubmed/17784946
http://dx.doi.org/10.1186/1471-2261-7-27
work_keys_str_mv AT claesneree theprecardiostudyprotocolarandomizedclinicaltrialofamultidisciplinaryelectroniccardiovascularpreventionprogramme
AT jacobsnele theprecardiostudyprotocolarandomizedclinicaltrialofamultidisciplinaryelectroniccardiovascularpreventionprogramme
AT claesneree precardiostudyprotocolarandomizedclinicaltrialofamultidisciplinaryelectroniccardiovascularpreventionprogramme
AT jacobsnele precardiostudyprotocolarandomizedclinicaltrialofamultidisciplinaryelectroniccardiovascularpreventionprogramme